glp-1 liver GLP-1R expression levels in the livers of NAFLD patients. a HE Revolutionizing MASLD treatment with GLP-1

Zhao J, Wu Y, Rong X, Zheng C, Guo J

They may upset your stomach

Fixed: Tapping the edges of the meal name in the meal selector wasn't opening the dropdown

Theoretical and route-specific risks FDA's 2024 review specifically flagged that no published human exposure data exists for the subcutaneous, transdermal, or intranasal routes that compounding pharmacies have offered

Clearly communicate aspiration risk to the team to align preparation and roles There are no formal ED-specific guidelines, but EM and anesthesia literature consistently emphasize increased vigilance rather than major practice change

The report concludes that as GLP-1 use explodes, payers face a dilemma balancing high drug costs against potential long-term health benefit